Jyrki Mattila - Net Worth and Insider Trading
Jyrki Mattila Net Worth
The estimated net worth of Jyrki Mattila is at least $33,287 dollars as of 2024-11-10. Jyrki Mattila is the Director of BioSpecifics Technologies Corp and owns about 376 shares of BioSpecifics Technologies Corp (BSTC) stock worth over $33,287. Details can be seen in Jyrki Mattila's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jyrki Mattila has not made any transactions after 2019-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jyrki Mattila
Jyrki Mattila Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jyrki Mattila owns 3 companies in total, including BioSpecifics Technologies Corp (BSTC) , Societal CDMO Inc (SCTL) , and Lipocine Inc (LPCN) .
Click here to see the complete history of Jyrki Mattila’s form 4 insider trades.
Insider Ownership Summary of Jyrki Mattila
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BSTC | BioSpecifics Technologies Corp | 2019-05-22 | director |
| SCTL | Societal CDMO Inc | 2017-08-21 | Executive VP & Business Dev. |
| LPCN | Lipocine Inc | 2015-05-15 | Chief Business Officer |
Jyrki Mattila Latest Holdings Summary
Jyrki Mattila currently owns a total of 1 stock. Jyrki Mattila owns 376 shares of BioSpecifics Technologies Corp (BSTC) as of May 22, 2019, with a value of $33,287.
Latest Holdings of Jyrki Mattila
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BSTC | BioSpecifics Technologies Corp | 2019-05-22 | 376 | 88.53 | 33,287 |
Holding Weightings of Jyrki Mattila
Jyrki Mattila Form 4 Trading Tracker
According to the SEC Form 4 filings, Jyrki Mattila has made a total of 0 transactions in BioSpecifics Technologies Corp (BSTC) over the past 5 years. The most-recent trade in BioSpecifics Technologies Corp is the sale of 18,750 shares on May 22, 2019, which brought Jyrki Mattila around $1 Million.
Insider Trading History of Jyrki Mattila
- 1
Jyrki Mattila Trading Performance
Jyrki Mattila Ownership Network
Ownership Network List of Jyrki Mattila
Ownership Network Relation of Jyrki Mattila
Jyrki Mattila Owned Company Details
What does BioSpecifics Technologies Corp do?
Who are the key executives at BioSpecifics Technologies Corp?
Jyrki Mattila is the director of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .
BioSpecifics Technologies Corp (BSTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp (BSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp (BSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioSpecifics Technologies Corp (BSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioSpecifics Technologies Corp Insider Transactions
Jyrki Mattila Mailing Address
Above is the net worth, insider trading, and ownership report for Jyrki Mattila. You might contact Jyrki Mattila via mailing address: Auxilium Pharmaceuticals, Inc., 40 Valley Stream Parkway, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
